Ketoconazole in the treatment of pityriasis versicolor: international review of clinical trials.
Multiple open and double-blind studies have confirmed the efficacy of ketoconazole in the treatment of pityriasis versicolor. Single-dose (400 mg) or short-course (200 mg/d for five days) therapy may be highly effective for selected patients with pityriasis versicolor. Toxicity seems to be minimal at this dosage.
Goodless
D R
DR
Department of Medicine, University of Florida College of Medicine, Gainesville 32610.
Ramos-Caro
F A
FA
Flowers
F P
FP
D006801:Humans; D007654:Ketoconazole / Q000009:adverse effects / Q000627:therapeutic use*; D014010:Tinea Versicolor / Q000188:drug therapy*
D007654:Ketoconazole